Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanbeizhu Han Capsule in Obstructive Sleep Apnea (Phase III)
CTR20221425Phase 3Completed
- Sponsor
- Dongyang Baorentang Pharmaceutical
- Start
- Jun 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sanbeizhuhan Capsule in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Dongyang Baorentang Pharmaceutical. Started Jun 2022; status: completed.
02
Drugs
Sanbeizhuhan Capsule
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on CTR20221425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221425.